Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT06647472
Active, not recruiting Observational

Proteomic Analysis on Myopic Children Using Orthokeratology Lenses With Good or Poor Myopic Control

NCT06647472 · tracked via the Priya Life Science Denmark tracker
Sponsor
Vejle Hospital
Phase
Observational
Started
2024-11-15
Last updated
2026-07-21

Condition(s) studied

MyopiaHealthyOrthokeratology

Study summary

The key objective of the study is to gain an understanding of the biochemical processes that contribute to orthokeratology lenses being more effective in specific individuals compared to others. With this knowledge, we hope to optimize treatment effectiveness in those currently experiencing less favorable outcomes from treatment in the future.

The primary aim is to investigate differences in protein levels in children using orthokeratology lenses with various effects of myopia control.

Hypothesis: There is a significant difference in the expression of molecules in children with various effects of myopia control.

Eligibility

Sex
ALL
Min age
5 Years
Max age
14 Years
Healthy volunteers
No
Inclusion Criteria: * Children treated with orthokeratology lenses. * Children on or above the 95th percentile of myopia growth curves for European children at the time of treatment initiation. * Treatment and follow-up duration ≥ 6 months. Exclusion Criteria: * Current use of eye drops. * Objective signs of dry eyes on slit-lamp examination. * Active eye infection.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Øjenafdelingen, Vejle Sygehus Vejle Denmark

More Vejle Hospital trials in Denmark

Optimising Mammography Screening Accuracy With Blood-based Biomarkers Enrolling by invitation
Shared Decision Making on Radiation Dose for Lung Malignancies Active, not recruiting
Reducing Breathlessness With Dronabinol in COPD Patients Active, not recruiting
Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities Recruiting
Risk-Based Lung Cancer Detection in COPD Patients Recruiting

Other trials for the same condition

FIT FIRST for the Bones Enrolling by invitation
Urinary Concentration After Salmeterol Recruiting
Identifying Biological Markers for Altitude Exposure and Use of Recombinant Human Erythropoietin (rHuEPO) Active, not recruiting
GastroFlow: Investigation of the Gastrointestinal Blood Flow in Patients With Postprandial Hypotension Enrolling by invitation
Optimistic and Pessimistic Dopamine Signals in the Human Brain: a Mapping and Modelling Study in Health and Parkinson's Disease Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06647472 on ClinicalTrials.gov ↗ ← All trials in Denmark